Peter Attia, MD
468 episodes listed below
Peter Attia evaluates longevity science, from CETP inhibitors to protein debates, through evidence.
The Peter Attia Drive treats longevity as a problem of evidence, prevention, and disciplined interpretation. Episodes move from peptides and ApoB to cardiorespiratory training, fiber, happiness, and mortality with an unusually high tolerance for nuance.
PRESS PLAY
The Peter Attia Drive is hosted by physician Peter Attia, who leads the show in two main formats: solo AMA and special episodes where he works through a single topic (peptides, Tylenol-pregnancy-autism headlines, the CETP inhibitor obicetrapib), and longer interview episodes with outside experts. Guests are typically researchers or clinicians in fields like obesity and nutrition (David Allison of Baylor College of Medicine), cardiology, oncology, and sleep medicine. The show also draws on its own archive, airing rebroadcasts and 'quarterly summary' episodes that recap multiple earlier guest conversations, and special compilations built from past interviews, such as one assembled from two prior conversations with Arthur Brooks on happiness. Attia frames his role as translating longevity science into accessible material and repeatedly emphasizes evaluating evidence, safety, and mechanism over marketing claims, particularly for wellness and biohacking products. Episode length varies widely, from shorter AMA segments around 20-30 minutes to full interviews and specials running 85-110 minutes. The show describes itself as funded by paid members rather than advertising. Listeners who benefit most are those interested in preventive medicine, nutrition debates, and a framework for critically assessing health headlines and products, rather than listeners seeking quick tips or entertainment-first content. Recurring non-clinical themes include gratitude, intentional living, and mortality, introduced through guests like Walter Green. The tone throughout is explanatory and evidence-focused, with Attia frequently distinguishing FDA-approved or trial-backed interventions from broader commercial claims.
Made for: Listeners interested in longevity science and preventive medicine who want evidence-based evaluation of nutrition, drug, and supplement claims.
What sets it apart: Episodes are structured around evaluating evidence and marketing claims for specific interventions (peptides, CETP inhibitors, protein intake) rather than general wellness advice, combined with recurring solo AMA deep dives and archive-based compilation episodes.
Expert insight on health, performance, longevity, critical thinking, and pursuing excellence. Dr. Peter Attia (Stanford/Hopkins/NIH-trained MD) talks with leaders in their fields.
Based on 4 episodes we listened to · September 2026
Peter Attia connects detailed physiology to practical health decisions while keeping uncertainty and changing evidence in view.
The Peter Attia Drive treats longevity as a chain of decisions that must survive contact with physiology and evidence. Peter Attia moves between focused explanations and AMA-style question sessions, building from disease mechanisms toward choices about prevention, exercise and…
Peter Attia turns longevity into risk management, then hands you ApoB and VO2 max as homework.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A brisk AMA on applying longevity tools to chronic disease risk, training, scans, habits, and prevention in real life.
Peter Attia's AMA #82 is a fast, practical pass through longevity questions that come up outside the clinic: how priorities change by decade, when prevention still pays off, what DEXA scans can tell you over time, and how habits, protein intake, stability work, and injury…
A technical, cautious case for why obicetrapib has put CETP inhibitors back on Attia's radar.
Peter Attia gives obicetrapib a full episode, using the CETP inhibitor to revisit a drug class that has had a messy cardiovascular history. The strongest section is the trial walk-through: Lilly's program failing to show benefit, Merck's anacetrapib showing a modest reduction in…
A clear cardio training primer for listeners who want endurance work to support aging, capacity, and independence.
Peter Attia uses this AMA preview to make a practical case for cardiorespiratory training as a way to protect healthspan, lifespan, and independence with age.
A clear Attia longevity primer on prevention, disease risk, and the limits of what we know.
Peter Attia uses this re-broadcast as a longevity primer, stepping back from the show's usual deep dives to answer foundational questions about cardiovascular disease, cancer, neurodegenerative disease, nutrition, exercise, sleep, and prevention.
Morning medical evidence, compressed for practice.
Medical research, translated through patient experience.
Midlife hormones, explained with momentum.
Peter Attia and Brian Grossberg explain why headache medicine relies on detailed history rather than a definitive CT or MRI finding, despite more than 300 headache types and causes.
Peter Attia frames AMA #83 of The Drive around peptides as a category that is “one of the most requested and most confusing topics” the show has covered.
AMA 82 is practical calibration, at least in this sneak peek.
The drug gets a cautious spotlight.
Cardiorespiratory fitness is the main thing on the table.
Peter Attia opens The Drive by saying his podcast, website, and weekly newsletter translate longevity science into accessible health and wellness content funded by members rather than paid ads.
This AMA episode addresses common listener questions on longevity interventions, cardiovascular risk, exercise motivation, metabolic health monitoring, and lifestyle strategies for optimal health.
The Drive Podcast rebroadcasts Peter Attia’s conversation with Walter Green around Thanksgiving, with Walter described as the founder of Say It Now and author of This Is The Moment.
Dr.
Dr.
Longevity starts with translation.
Dr.
Dr.
Peter Attia opens The Drive by saying his podcast, website, and weekly newsletter are built to translate longevity science into accessible health content without paid ads.
Peter Attia opens The Drive with the recent headlines linking acetaminophen, or Tylenol, use during pregnancy to autism, and says the reaction has included questions from patients, listeners, friends, and family.
Dr.
Dr.
Dr.
Dr.
Dr.
Dr.
Dr.
Dr.
Dr.
Dr.
Dr.
Peter Atiyah uses this quarterly summary of The Drive to revisit interviews with Jeff English, Ashley Mason, Sanjay Mehta, Sean Mackey, and Sue Desmond Hellman.
Dr.
Peter Attia visits a senior living center to discuss practical strategies for improving longevity and healthspan with an aging population, focusing on adding quality life to years.
Dr.
Peter Atiyah summarizes key insights from recent podcast interviews on topics including aerobic exercise, metabolic health, healthcare economics, neurodevelopmental disorders, and strength training.
Dr.
Dr.